324 related articles for article (PubMed ID: 30658253)
1. Generation of induced pluripotent stem cell line, ICGi007-A, by reprogramming peripheral blood mononuclear cells from a patient with Huntington's disease.
Grigor'eva EV; Malankhanova TB; Surumbayeva A; Minina JM; Morozov VV; Abramycheva NY; Illarioshkin SN; Malakhova AA; Zakian SM
Stem Cell Res; 2019 Jan; 34():101382. PubMed ID: 30658253
[TBL] [Abstract][Full Text] [Related]
2. Generation of induced pluripotent stem cell line ICGi018-A from peripheral blood mononuclear cells of a patient with Huntington's disease.
Malakhova AA; Grigor'eva EV; Malankhanova TB; Pavlova SV; Valetdinova KR; Abramycheva NY; Vetchinova AS; Illarioshkin SN; Zakian SM
Stem Cell Res; 2020 Apr; 44():101743. PubMed ID: 32179492
[TBL] [Abstract][Full Text] [Related]
3. Generation of induced pluripotent stem cell line, ICGi033-A, by reprogramming peripheral blood mononuclear cells from a patient with Huntington's disease.
Grigor'eva EV; Malakhova AA; Sorogina DA; Pavlova SV; Malankhanova TB; Abramycheva NY; Klyushnikov SA; Illarioshkin SN; Zakian SM
Stem Cell Res; 2022 Aug; 63():102868. PubMed ID: 35872525
[TBL] [Abstract][Full Text] [Related]
4. Generation of induced pluripotent stem cell line, CSSi004-A (2962), from a patient diagnosed with Huntington's disease at the presymptomatic stage.
Bidollari E; Rotundo G; Ferrari D; Candido O; Bernardini L; Consoli F; De Luca A; Santimone I; Lamorte G; Ilari A; Squitieri F; Vescovi AL; Rosati J
Stem Cell Res; 2018 Apr; 28():145-148. PubMed ID: 29486399
[TBL] [Abstract][Full Text] [Related]
5. Generation of two iPSC lines, (ICGi015-A and ICGi015-B), by reprogramming peripheral blood mononuclear cells from a patient with Parkinson's disease.
Sharipova DV; Kovalenko VR; Bairamova EM; Vartanova VA; Grigor'eva EV; Vyatkin YV; Khabarova EA; Rzaev DA; Zakian SM; Medvedev SP
Stem Cell Res; 2019 Dec; 41():101652. PubMed ID: 31733442
[TBL] [Abstract][Full Text] [Related]
6. Generation of induced pluripotent stem cells from three individuals with Huntington's disease.
Miller DC; Lisowski P; Lickfett S; Mlody B; Bünning M; Genehr C; Ulrich C; Wanker EE; Diecke S; Priller J; Prigione A
Stem Cell Res; 2022 Dec; 65():102976. PubMed ID: 36434993
[TBL] [Abstract][Full Text] [Related]
7. Cellular Models: HD Patient-Derived Pluripotent Stem Cells.
Geater C; Hernandez S; Thompson L; Mattis VB
Methods Mol Biol; 2018; 1780():41-73. PubMed ID: 29856014
[TBL] [Abstract][Full Text] [Related]
8. Generation of iPSC lines from peripheral blood mononuclear cells from 5 healthy adults.
Vlahos K; Sourris K; Mayberry R; McDonald P; Bruveris FF; Schiesser JV; Bozaoglu K; Lockhart PJ; Stanley EG; Elefanty AG
Stem Cell Res; 2019 Jan; 34():101380. PubMed ID: 30605840
[TBL] [Abstract][Full Text] [Related]
9. Generation of an induced pluripotent stem cell line from a Huntington's disease patient with a long HTT-PolyQ sequence.
Miller DC; Lisowski P; Genehr C; Wanker EE; Priller J; Prigione A; Diecke S
Stem Cell Res; 2023 Apr; 68():103056. PubMed ID: 36863131
[TBL] [Abstract][Full Text] [Related]
10. Astrocytes generated from patient induced pluripotent stem cells recapitulate features of Huntington's disease patient cells.
Juopperi TA; Kim WR; Chiang CH; Yu H; Margolis RL; Ross CA; Ming GL; Song H
Mol Brain; 2012 May; 5():17. PubMed ID: 22613578
[TBL] [Abstract][Full Text] [Related]
11. Generation of an iPSC line (SDQLCHi015-A) from peripheral blood mononuclear cells of a patient with mental retardation type 15 carrying c.1007_1011del, p.(Ile336fs) in CUL4B gene.
Guan J; Liu X; Zhang H; Lv Y; Wang X; Yang X; Ma Y; Liu Q; Liu Y; Sun W
Stem Cell Res; 2019 Dec; 41():101628. PubMed ID: 31678776
[TBL] [Abstract][Full Text] [Related]
12. Generation of an induced pluripotent stem cell line, ICGi014-A, by reprogramming peripheral blood mononuclear cells from a patient with homozygous D90A mutation in SOD1 causing Amyotrophic lateral sclerosis.
Ustyantseva EI; Medvedev SP; Vetchinova AS; Illarioshkin SN; Leonov SV; Zakian SM
Stem Cell Res; 2020 Jan; 42():101675. PubMed ID: 31830646
[TBL] [Abstract][Full Text] [Related]
13. Generation of two spinal muscular atrophy (SMA) type I patient-derived induced pluripotent stem cell (iPSC) lines and two SMA type II patient-derived iPSC lines.
Valetdinova KR; Maretina MA; Kuranova ML; Grigor'eva EV; Minina YM; Kizilova EA; Kiselev AV; Medvedev SP; Baranov VS; Zakian SM
Stem Cell Res; 2019 Jan; 34():101376. PubMed ID: 30660867
[TBL] [Abstract][Full Text] [Related]
14. An integration-free iPSC line (SDQLCHi013-A) derived from a patient with maple syrup urine disease carrying compound heterozygote mutations in BCKDHA gene.
Zhang H; Ma Y; Li X; Yang X; Li Y; Guan J; Dong R; Gai Z; Liu Y
Stem Cell Res; 2019 Dec; 41():101585. PubMed ID: 31775088
[TBL] [Abstract][Full Text] [Related]
15. Quantitative proteomic analysis of induced pluripotent stem cells derived from a human Huntington's disease patient.
Chae JI; Kim DW; Lee N; Jeon YJ; Jeon I; Kwon J; Kim J; Soh Y; Lee DS; Seo KS; Choi NJ; Park BC; Kang SH; Ryu J; Oh SH; Shin DA; Lee DR; Do JT; Park IH; Daley GQ; Song J
Biochem J; 2012 Sep; 446(3):359-71. PubMed ID: 22694310
[TBL] [Abstract][Full Text] [Related]
16. Neuronal properties, in vivo effects, and pathology of a Huntington's disease patient-derived induced pluripotent stem cells.
Jeon I; Lee N; Li JY; Park IH; Park KS; Moon J; Shim SH; Choi C; Chang DJ; Kwon J; Oh SH; Shin DA; Kim HS; Do JT; Lee DR; Kim M; Kang KS; Daley GQ; Brundin P; Song J
Stem Cells; 2012 Sep; 30(9):2054-62. PubMed ID: 22628015
[TBL] [Abstract][Full Text] [Related]
17. Generation of two induced pluripotent stem cells lines from a Mucopolysaccharydosis IIIB (MPSIIIB) patient.
Vallejo-Diez S; Fleischer A; Martín-Fernández JM; Sánchez-Gilabert A; Bachiller D
Stem Cell Res; 2018 Dec; 33():180-184. PubMed ID: 30408744
[TBL] [Abstract][Full Text] [Related]
18. Generation of human induced pluripotent stem cells from peripheral blood mononuclear cells of a Senior-Loken syndrome patient.
Park H; Han J; Lee Y; Kwak S; Koo SK
Stem Cell Res; 2019 Dec; 41():101648. PubMed ID: 31734643
[TBL] [Abstract][Full Text] [Related]
19. Generation of integration-free induced pluripotent stem cells (GZHMUi001-A) by reprogramming peripheral blood mononuclear cells from a 47, XXX syndrome patient.
Chen Y; Ou Z; Song B; Xian Y; Ouyang S; Xie Y; Xue Y; Sun X
Stem Cell Res; 2017 Aug; 23():57-60. PubMed ID: 28925367
[TBL] [Abstract][Full Text] [Related]
20. Derivation of Huntington's disease-affected human embryonic stem cell lines.
Bradley CK; Scott HA; Chami O; Peura TT; Dumevska B; Schmidt U; Stojanov T
Stem Cells Dev; 2011 Mar; 20(3):495-502. PubMed ID: 20649476
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
